1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Ovarian Cancer Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 PARP 1.2.3 PD-L1 1.2.4 Angiogenesis Inhibitors 1.3 Market by Application 1.3.1 Global Ovarian Cancer Therapeutics Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hosptial 1.3.3 Research 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Ovarian Cancer Therapeutics Market Perspective (2017-2028) 2.2 Ovarian Cancer Therapeutics Growth Trends by Region 2.2.1 Ovarian Cancer Therapeutics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Ovarian Cancer Therapeutics Historic Market Size by Region (2017-2022) 2.2.3 Ovarian Cancer Therapeutics Forecasted Market Size by Region (2023-2028) 2.3 Ovarian Cancer Therapeutics Market Dynamics 2.3.1 Ovarian Cancer Therapeutics Industry Trends 2.3.2 Ovarian Cancer Therapeutics Market Drivers 2.3.3 Ovarian Cancer Therapeutics Market Challenges 2.3.4 Ovarian Cancer Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Ovarian Cancer Therapeutics Players by Revenue 3.1.1 Global Top Ovarian Cancer Therapeutics Players by Revenue (2017-2022) 3.1.2 Global Ovarian Cancer Therapeutics Revenue Market Share by Players (2017-2022) 3.2 Global Ovarian Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Ovarian Cancer Therapeutics Revenue 3.4 Global Ovarian Cancer Therapeutics Market Concentration Ratio 3.4.1 Global Ovarian Cancer Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Ovarian Cancer Therapeutics Revenue in 2021 3.5 Ovarian Cancer Therapeutics Key Players Head office and Area Served 3.6 Key Players Ovarian Cancer Therapeutics Product Solution and Service 3.7 Date of Enter into Ovarian Cancer Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Ovarian Cancer Therapeutics Breakdown Data by Type 4.1 Global Ovarian Cancer Therapeutics Historic Market Size by Type (2017-2022) 4.2 Global Ovarian Cancer Therapeutics Forecasted Market Size by Type (2023-2028) 5 Ovarian Cancer Therapeutics Breakdown Data by Application 5.1 Global Ovarian Cancer Therapeutics Historic Market Size by Application (2017-2022) 5.2 Global Ovarian Cancer Therapeutics Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Ovarian Cancer Therapeutics Market Size (2017-2028) 6.2 North America Ovarian Cancer Therapeutics Market Size by Country (2017-2022) 6.3 North America Ovarian Cancer Therapeutics Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Ovarian Cancer Therapeutics Market Size (2017-2028) 7.2 Europe Ovarian Cancer Therapeutics Market Size by Country (2017-2022) 7.3 Europe Ovarian Cancer Therapeutics Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Ovarian Cancer Therapeutics Market Size (2017-2028) 8.2 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Country (2017-2022) 8.3 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Ovarian Cancer Therapeutics Market Size (2017-2028) 9.2 Latin America Ovarian Cancer Therapeutics Market Size by Country (2017-2022) 9.3 Latin America Ovarian Cancer Therapeutics Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Ovarian Cancer Therapeutics Market Size (2017-2028) 10.2 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2017-2022) 10.3 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Bristol Myers Squibb Company 11.1.1 Bristol Myers Squibb Company Company Detail 11.1.2 Bristol Myers Squibb Company Business Overview 11.1.3 Bristol Myers Squibb Company Ovarian Cancer Therapeutics Introduction 11.1.4 Bristol Myers Squibb Company Revenue in Ovarian Cancer Therapeutics Business (2017-2022) 11.1.5 Bristol Myers Squibb Company Recent Development 11.2 Eli Lilly and Company 11.2.1 Eli Lilly and Company Company Detail 11.2.2 Eli Lilly and Company Business Overview 11.2.3 Eli Lilly and Company Ovarian Cancer Therapeutics Introduction 11.2.4 Eli Lilly and Company Revenue in Ovarian Cancer Therapeutics Business (2017-2022) 11.2.5 Eli Lilly and Company Recent Development 11.3 GlaxoSmithKline Plc 11.3.1 GlaxoSmithKline Plc Company Detail 11.3.2 GlaxoSmithKline Plc Business Overview 11.3.3 GlaxoSmithKline Plc Ovarian Cancer Therapeutics Introduction 11.3.4 GlaxoSmithKline Plc Revenue in Ovarian Cancer Therapeutics Business (2017-2022) 11.3.5 GlaxoSmithKline Plc Recent Development 11.4 Janssen Pharmaceuticals 11.4.1 Janssen Pharmaceuticals Company Detail 11.4.2 Janssen Pharmaceuticals Business Overview 11.4.3 Janssen Pharmaceuticals Ovarian Cancer Therapeutics Introduction 11.4.4 Janssen Pharmaceuticals Revenue in Ovarian Cancer Therapeutics Business (2017-2022) 11.4.5 Janssen Pharmaceuticals Recent Development 11.5 Genentech Inc. 11.5.1 Genentech Inc. Company Detail 11.5.2 Genentech Inc. Business Overview 11.5.3 Genentech Inc. Ovarian Cancer Therapeutics Introduction 11.5.4 Genentech Inc. Revenue in Ovarian Cancer Therapeutics Business (2017-2022) 11.5.5 Genentech Inc. Recent Development 11.6 Astra Zeneca 11.6.1 Astra Zeneca Company Detail 11.6.2 Astra Zeneca Business Overview 11.6.3 Astra Zeneca Ovarian Cancer Therapeutics Introduction 11.6.4 Astra Zeneca Revenue in Ovarian Cancer Therapeutics Business (2017-2022) 11.6.5 Astra Zeneca Recent Development 11.7 Boehringer Ingelheim GmbH 11.7.1 Boehringer Ingelheim GmbH Company Detail 11.7.2 Boehringer Ingelheim GmbH Business Overview 11.7.3 Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Introduction 11.7.4 Boehringer Ingelheim GmbH Revenue in Ovarian Cancer Therapeutics Business (2017-2022) 11.7.5 Boehringer Ingelheim GmbH Recent Development 11.8 Hoffmann La Roche Ltd. 11.8.1 Hoffmann La Roche Ltd. Company Detail 11.8.2 Hoffmann La Roche Ltd. Business Overview 11.8.3 Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Introduction 11.8.4 Hoffmann La Roche Ltd. Revenue in Ovarian Cancer Therapeutics Business (2017-2022) 11.8.5 Hoffmann La Roche Ltd. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Ovarian Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of PARP Table 3. Key Players of PD-L1 Table 4. Key Players of Angiogenesis Inhibitors Table 5. Global Ovarian Cancer Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Ovarian Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Ovarian Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Ovarian Cancer Therapeutics Market Share by Region (2017-2022) Table 9. Global Ovarian Cancer Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Ovarian Cancer Therapeutics Market Share by Region (2023-2028) Table 11. Ovarian Cancer Therapeutics Market Trends Table 12. Ovarian Cancer Therapeutics Market Drivers Table 13. Ovarian Cancer Therapeutics Market Challenges Table 14. Ovarian Cancer Therapeutics Market Restraints Table 15. Global Ovarian Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Ovarian Cancer Therapeutics Market Share by Players (2017-2022) Table 17. Global Top Ovarian Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer Therapeutics as of 2021) Table 18. Ranking of Global Top Ovarian Cancer Therapeutics Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Ovarian Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Ovarian Cancer Therapeutics Product Solution and Service Table 22. Date of Enter into Ovarian Cancer Therapeutics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Ovarian Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Ovarian Cancer Therapeutics Revenue Market Share by Type (2017-2022) Table 26. Global Ovarian Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Ovarian Cancer Therapeutics Revenue Market Share by Type (2023-2028) Table 28. Global Ovarian Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Ovarian Cancer Therapeutics Revenue Market Share by Application (2017-2022) Table 30. Global Ovarian Cancer Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Ovarian Cancer Therapeutics Revenue Market Share by Application (2023-2028) Table 32. North America Ovarian Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Ovarian Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Ovarian Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Ovarian Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Ovarian Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Ovarian Cancer Therapeutics Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Ovarian Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Ovarian Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 42. Bristol Myers Squibb Company Company Detail Table 43. Bristol Myers Squibb Company Business Overview Table 44. Bristol Myers Squibb Company Ovarian Cancer Therapeutics Product Table 45. Bristol Myers Squibb Company Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 46. Bristol Myers Squibb Company Recent Development Table 47. Eli Lilly and Company Company Detail Table 48. Eli Lilly and Company Business Overview Table 49. Eli Lilly and Company Ovarian Cancer Therapeutics Product Table 50. Eli Lilly and Company Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 51. Eli Lilly and Company Recent Development Table 52. GlaxoSmithKline Plc Company Detail Table 53. GlaxoSmithKline Plc Business Overview Table 54. GlaxoSmithKline Plc Ovarian Cancer Therapeutics Product Table 55. GlaxoSmithKline Plc Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 56. GlaxoSmithKline Plc Recent Development Table 57. Janssen Pharmaceuticals Company Detail Table 58. Janssen Pharmaceuticals Business Overview Table 59. Janssen Pharmaceuticals Ovarian Cancer Therapeutics Product Table 60. Janssen Pharmaceuticals Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 61. Janssen Pharmaceuticals Recent Development Table 62. Genentech Inc. Company Detail Table 63. Genentech Inc. Business Overview Table 64. Genentech Inc. Ovarian Cancer Therapeutics Product Table 65. Genentech Inc. Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 66. Genentech Inc. Recent Development Table 67. Astra Zeneca Company Detail Table 68. Astra Zeneca Business Overview Table 69. Astra Zeneca Ovarian Cancer Therapeutics Product Table 70. Astra Zeneca Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 71. Astra Zeneca Recent Development Table 72. Boehringer Ingelheim GmbH Company Detail Table 73. Boehringer Ingelheim GmbH Business Overview Table 74. Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Product Table 75. Boehringer Ingelheim GmbH Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 76. Boehringer Ingelheim GmbH Recent Development Table 77. Hoffmann La Roche Ltd. Company Detail Table 78. Hoffmann La Roche Ltd. Business Overview Table 79. Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Product Table 80. Hoffmann La Roche Ltd. Revenue in Ovarian Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 81. Hoffmann La Roche Ltd. Recent Development Table 82. Research Programs/Design for This Report Table 83. Key Data Information from Secondary Sources Table 84. Key Data Information from Primary Sources List of Figures Figure 1. Global Ovarian Cancer Therapeutics Market Share by Type: 2021 VS 2028 Figure 2. PARP Features Figure 3. PD-L1 Features Figure 4. Angiogenesis Inhibitors Features Figure 5. Global Ovarian Cancer Therapeutics Market Share by Application in 2021 & 2028 Figure 6. Hosptial Case Studies Figure 7. Research Case Studies Figure 8. Ovarian Cancer Therapeutics Report Years Considered Figure 9. Global Ovarian Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Ovarian Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Ovarian Cancer Therapeutics Market Share by Region: 2021 VS 2028 Figure 12. Global Ovarian Cancer Therapeutics Market Share by Players in 2021 Figure 13. Global Top Ovarian Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer Therapeutics as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Ovarian Cancer Therapeutics Revenue in 2021 Figure 15. North America Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Ovarian Cancer Therapeutics Market Share by Country (2017-2028) Figure 17. United States Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Ovarian Cancer Therapeutics Market Share by Country (2017-2028) Figure 21. Germany Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Ovarian Cancer Therapeutics Market Share by Region (2017-2028) Figure 29. China Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Ovarian Cancer Therapeutics Market Share by Country (2017-2028) Figure 37. Mexico Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Ovarian Cancer Therapeutics Market Share by Country (2017-2028) Figure 41. Turkey Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Ovarian Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Bristol Myers Squibb Company Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022) Figure 44. Eli Lilly and Company Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022) Figure 45. GlaxoSmithKline Plc Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022) Figure 46. Janssen Pharmaceuticals Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022) Figure 47. Genentech Inc. Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022) Figure 48. Astra Zeneca Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022) Figure 49. Boehringer Ingelheim GmbH Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022) Figure 50. Hoffmann La Roche Ltd. Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2017-2022) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Bristol Myers Squibb Company Eli Lilly and Company GlaxoSmithKline Plc Janssen Pharmaceuticals Genentech Inc. Astra Zeneca Boehringer Ingelheim GmbH Hoffmann La Roche Ltd.